Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Environ Int. 2017 Nov 20;111:23–31. doi: 10.1016/j.envint.2017.11.011

Table 3.

Associations between urinary concentration of DINCH metabolites, metabolites of high molecular weight phthalates, and ΣDEHP and intermediate outcomes of assisted reproduction (n=136 women/cycles).

Adjusted Mean (95% CI)1
SG-adjusted Biomarker Concentration (Range) N Total Oocytes Mature Oocytes Fertilized Oocytes Top Quality Embryos
Σ DEHP (μmol/L)
 T1 (0.02–0.12) 45 11.4 (10.4, 12.4) 8.8 (8.0, 9.7) 5.9 (5.3, 6.7) 3.0 (2.5, 3.5)
 T2 (0.12–0.22) 46 9.0 (8.1, 9.9)* 7.3 (6.6, 8.1)* 5.0 (4.4, 5.7) 2.2 (1.8, 2.7)*
 T3 (0.22–2.65) 45 8.5 (7.7, 9.4)* 7.1 (6.4, 7.9)* 4.7 (4.1, 5.4)* 1.9 (1.5, 2.3)*
P-trend2 <0.001 0.02 0.02 0.002
MEHP (μg/L)
 T1 (0.00–2.71) 45 9.8 (8.9, 10.7) 7.3 (6.6, 8.2) 4.8 (4.2, 5.5) 2.5 (2.0, 3.0)
 T2 (2.72–6.07) 46 10.1 (9.3, 11.1) 8.1 (7.3, 9.0) 5.6 (5.0, 6.4) 2.5 (2.1, 3.0)
 T3 (6.08–70.6) 45 8.9 (8.0, 9.8) 7.8 (7.0, 8.6) 5.2 (4.6, 5.9) 2.1 (1.7, 2.6)
P-trend 0.07 0.69 0.78 0.19
MEHHP (μg/L)
 T1 (2.10–9.73) 45 11.6 (10.7, 12.7) 9.0 (8.1, 9.9) 6.0 (5.3, 6.8) 2.9 (2.4, 3.4)
 T2 (9.74–17.9) 46 9.3 (8.5, 10.3)* 7.5 (6.8, 8.3)* 5.1 (4.5, 5.8) 2.3 (1.9, 2.8)
 T3 (18.0–215) 45 7.9 (7.1, 8.7)* 6.7 (6.0, 7.5)* 4.6 (4.0, 5.2)* 1.9 (1.5, 2.4)*
P-trend <0.001 <0.001 0.006 0.006
MEOHP (μg/L)
 T1 (1.40–7.49) 45 11.6 (10.6, 12.7) 9.0 (8.1, 9.9) 6.1 (5.4, 6.9) 3.0 (2.5, 3.6)
 T2 (7.50–13.3) 46 9.2 (8.4, 10.2)* 7.5 (6.8, 8.3)* 5.1 (4.5, 5.8)* 2.2 (1.8, 2.7)*
 T3 (13.4–145) 45 8.0 (7.2, 8.8)* 6.7 (6.0, 7.5)* 4.5 (3.9, 5.1)* 1.9 (1.5, 2.3)*
 P-trend <0.001 <0.001 0.002 0.002
MECPP (μg/L)
 T1 (1.68–15.3) 45 11.0 (10.1, 12.0) 8.3 (7.5, 9.2) 5.5 (4.8, 6.2) 2.5 (2.1, 3.1)
 T2 (15.4–26.3) 45 9.4 (8.5, 10.3)* 7.8 (7.0, 8.6) 5.5 (4.8, 6.2) 2.8 (2.4, 3.3)
 T3 (26.4–371) 46 8.5 (7.7, 9.4)* 7.1 (6.4, 7.9)* 4.8 (4.2, 5.4) 1.8 (1.4, 2.2)
P-trend <0.001 0.03 0.10 0.004
MBzP (μg/L)
 T1 (0.00–1.23) 45 9.6 (8.7, 10.6) 7.6 (6.9, 8.5) 5.2 (4.6, 5.9) 2.5 (2.1, 3.0)
 T2 (1.24–2.35) 46 9.5 (8.7, 10.4) 7.7 (7.0, 8.6) 5.0 (4.4, 5.7) 2.2 (1.8, 2.6)
 T3 (2.35–382) 45 9.7 (8.8, 10.6) 7.8 (7.1, 8.7) 5.4 (4.8, 6.2) 2.5 (2.0, 3.0)
P-trend 0.86 0.74 0.57 0.93
MCPP (μg/L)
 T1 (0–0.91) 44 8.9 (8.1, 9.9) 7.2 (6.4, 8.0) 4.8 (4.2, 5.5) 2.4 (1.9, 2.9)
 T2 (0.92–1.68) 46 10.1 (9.3,11.1) 8.3 (7.5, 9.2) 5.6 (5.0, 6.4) 2.6 (2.2, 3.1)
 T3 (1.69–131) 46 9.7 (8.8, 10.6) 7.7 (6.9, 8.6) 5.2 (4.6, 5.9) 2.2 (1.8, 2.6)
P-trend 0.48 0.62 0.64 0.37
MCOP (μg/L)
 T1 (1.68–6.15) 45 9.2 (8.3, 10.1) 7.2 (6.4, 8.0) 5.0 (4.4, 5.7) 2.5 (2.0, 3.0)
 T2 (6.16–11.14) 46 10.2 (9.3, 11.2)* 8.4 (7.6, 9.3)* 5.7 (5.0, 6.4) 2.5 (2.1, 3.0)
 T3 (11.15–1344) 45 9.4 (8.5, 10.3) 7.6 (6.8, 8.4) 5.0 (4.4, 5.7) 2.1 (1.7, 2.6)
P-trend 0.75 0.91 0.51 0.20
MiNP (μg/L)
 T1 (<LOD) 66 9.9 (9.2, 10.7) 7.8 (7.2, 8.5) 5.2 (4.7, 5.8) 2.6 (2.2, 3.0)
 T2 (0.50–1.40) 35 9.5 (8.5, 10.5) 7.6 (6.8, 8.6) 5.0 (4.4, 5.8) 2.1 (1.7, 2.7)
 T3 (1.41–263) 35 9.2 (8.2, 10.2)* 7.6 (6.7, 8.6) 5.4 (4.7, 6.3) 2.1 (1.7, 2.7)
P-trend 0.28 0.74 0.63 0.18
MONP (μg/L)
 T1 (0.56–2.79) 45 9.8 (8.9, 10.7) 7.7 (6.9, 8.5) 5.3 (4.6, 6.0) 2.5 (2.0, 3.0)
 T2 (2.80–4.83) 46 9.4 (8.5, 10.3) 7.6 (6.8, 8.4) 4.9 (4.3, 5.6) 2.4 (2.0, 2.9)
 T3 (4.84–902) 45 9.7 (8.8, 10.6) 7.9 (7.2, 8.8) 5.5 (4.9, 6.3) 2.2 (1.8, 2.7)
P-trend 0.98 0.57 0.41 0.48
MCNP (μg/L)
 T1 (0.21–0.83) 47 10.1 (9.2, 11.1) 7.8 (7.1, 8.7) 5.3 (4.7, 6.0) 2.4 (2.0, 2.9)
 T2 (0.84–1.67) 44 9.0 (8.2, 10.0) 7.2 (6.4, 8.1) 4.9 (4.2, 5.6) 2.0 (1.6, 2.5)
 T3 (1.68–46.0) 45 9.6 (8.7, 10.6) 8.1 (7.3, 9.0) 5.5 (4.9, 6.2) 2.7 (2.2, 3.2)
P-trend 0.76 0.36 0.44 0.22
MHiNCH (μg/L)
 T1 (0.19–0.91) 45 10.1 (9.2, 11.1) 8.0 (7.2, 8.9) 5.0 (4.4, 5.7) 2.0 (1.6, 2.4)
 T2 (0.92–1.77) 45 8.3 (7.5, 9.2)* 6.6 (5.9, 7.4)* 4.7 (4.1, 5.3) 2.5 (2.0, 3.0)
 T3 (1.78–74.8) 46 10.3 (9.4, 11.3) 8.6 (7.8, 9.5) 6.0 (5.3, 6.8)* 2.6 (2.2, 3.2)*
P-trend 0.20 0.06 0.008 0.07
MCOCH (μg/L)
 T1 (0–0.45) 45 9.0 (8.1, 9.9) 7.4 (6.6, 8.2) 4.7 (4.1, 5.4) 2.3 (1.9, 2.8)
 T2 (0.46–0.84) 45 10.4 (9.5, 11.4) 8.0 (7.2, 8.9) 5.4 (4.7, 6.1) 2.1 (1.7, 2.6)
 T3 (0.85–26.6) 46 9.5 (8.6, 10.4) 7.8 (7.0, 8.6) 5.6 (4.9, 6.3) 2.6 (2.2, 3.2)
P-trend 0.97 0.70 0.15 0.18
MEHHTP (μg/L)
 T1 (0–1.62) 45 10.0 (9.1, 11.0) 7.9 (7.1, 8.8) 5.3 (4.6, 6.0) 2.3 (1.9, 2.8)
 T2 (1.63–3.71) 46 9.6 (8.7, 10.5) 7.8 (7.0, 8.7) 5.3 (4.6, 6.0) 2.6 (2.1, 3.1)
 T3 (3.72–386) 45 9.3 (8.4, 10.2) 7.5 (6.7, 8.3) 5.1 (4.5, 5.8) 2.2 (1.8, 2.7)
P-trend 0.32 0.47 0.75 0.54
MECPTP (μg/L)
 T1 (0.84–5.53) 45 8.8 (8.0, 9.7) 6.9 (6.1, 7.7) 4.6 (4.0, 5.2) 2.0 (1.6, 2.5)
 T2 (5.54–13.25) 45 10.0 (9.2, 11.0) 8.3 (7.5, 9.2)* 5.6 (5.0, 6.3)* 2.6 (2.2, 3.1)
 T3 (13.26–2856) 46 9.9 (9.1, 10.9) 8.0 (7.2, 8.8) 5.5 (4.8, 6.2)* 2.5 (2.0, 2.9)
P-trend 0.19 0.21 0.16 0.40
1

Models were run using Poisson regression with log link. All data are presented as adjusted mean counts controlling for maternal age, body mass index, and current smoking status.

*

p-value for T3 or T2 vs. T1 < 0.05;

p-value for T3 vs. T2 < 0.05